LISA HU: Open Payments
NPI 1730579376 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 86 payments from 17 companies in 2025. Trend: 2023 $1,847 · 2024 $1,594 · 2025 $2,205
Food & beverage: $2,205
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 22 | $577 |
| UCB, Inc. | 12 | $315 |
| ABBVIE INC. | 13 | $278 |
| Novartis Pharmaceuticals Corporation | 9 | $190 |
| Incyte Corporation | 7 | $181 |
| Galderma Laboratories, L.P. | 1 | $148 |
| Mayne Pharma Commercial LLC | 8 | $136 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Biotech, Inc. | 3 | $64 |
| PFIZER INC. | 3 | $55 |
Products named: Zoryve, Bimzelx, COSENTYX, OPZELURA, RINVOQ, NEMLUVIO, Sotyktu, SKYRIZI.
Industry payments across TX — which companies pay providers there.
